GM Up on Q4 Beat & Raise; UPS, Pfizer Mixed
https://www.zacks.com/stock/news/2218048/gm-up-on-q4-beat-raise-ups-pfizer-mixed?cid=CS-ZC-FT-ahead_of_wall_street-2218048
Jan 30, 2024 - Aside from a cavalcade of earnings, Case-Shiller came in lower month over month and JOLTS are out after the open.
0
Calix (CALX) Q4 Earnings Beat Estimates, Revenues Up Y/Y
https://www.zacks.com/stock/news/2218228/calix-calx-q4-earnings-beat-estimates-revenues-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2218228
Jan 30, 2024 - Calix's (CALX) top line benefits from growth in the cloud and managed services for Broadband Service Providers in the fourth quarter.
0
Why UPS Stock Is Rolling Downhill Today
https://www.fool.com/investing/2024/01/30/why-ups-stock-is-rolling-downhill-today/?source=iedfolrf0000001
Jan 30, 2024 - The company's guidance for 2024 underwhelmed.
0
Are Industry Challenges Finally Going to Catch Up to Altria Stock?
https://www.fool.com/investing/2024/01/30/are-industry-challenges-catch-up-altria-stock/?source=iedfolrf0000001
Jan 30, 2024 - The company's efforts to move into the cannabis and vaping businesses have not succeeded so far.
0
UPS to cut 12,000 jobs 5 months after reaching union deal as revenue outlook for year disappoints
https://www.startribune.com/ups-stock-down-before-market-open-as-company-gives-softer-than-expected-full-year-revenue-outlook/600339584/
Jan 30, 2024 - Follow the StarTribune for the news, photos and videos from the Twin Cities and beyond.
0
Lake Street mainstay Soderberg's floral shop reopens, gearing up for Valentine's Day
https://www.startribune.com/soderberg-lake-street-new-owner-george-floyd/600339565/
Jan 30, 2024 - A St. Paul florist is the new owner of the nearly 100-year-old Lake Street fixture.
0
Leerink ups 2seventy to outperform, cites attractiveness as takeover target
https://seekingalpha.com/news/4060882-leerink-ups-2seventy-to-outperform-cites-attractiveness-as-takeover-target?source=feed_sector_healthcare
Jan 31, 2024 - Leerink has upgraded 2seventy bio (TSVT) to outperform, citing the company’s attractiveness as an acquisition target. “While a commercial company with flat reve
0
2seventy bio (TSVT) Divests R&D Assets to Regeneron, Stock Up
https://www.zacks.com/stock/news/2218877/2seventy-bio-tsvt-divests-r-d-assets-to-regeneron-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2218877
Jan 31, 2024 - 2seventy bio (TSVT) inks an asset purchase agreement with Regeneron to sell its oncology and autoimmune pipeline to the latter.
0
BD's (BDX) Tie-Up to Offer AI-Based Digital System for Pap Test
https://www.zacks.com/stock/news/2218936/bd-s-bdx-tie-up-to-offer-ai-based-digital-system-for-pap-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2218936
Jan 31, 2024 - BD's (BDX) latest partnership is likely to aid cytotechnologists and pathologists to efficiently identify evidence of cervical cancer and pre-cancerous lesions.
0
NVR Q4 Earnings Beat, Homebuilding Revenues Lag, Orders Up 25%
https://www.zacks.com/stock/news/2218931/nvr-q4-earnings-beat-homebuilding-revenues-lag-orders-up-25?cid=CS-ZC-FT-analyst_blog|earnings_article-2218931
Jan 31, 2024 - NVR's fourth-quarter 2023 results are hurt by higher rates during the period compared to a year ago. Yet, improved demand trends led to higher orders.
0